Evidence map›Paper›PMID 32953763›Full record

ReviewAnnals of translational medicine2020

Percutaneous mitral repair: current and future devices.

Rodrigo Estévez-Loureiro, Tomás Benito-González, Carmen Garrote-Coloma, Felipe Fernández-Vázquez, Pablo Avanzas, Miguel Piñón, Isaac Pascual

Abstract readReview
In one paragraph

Review in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rodrigo Estévez-LoureiroInterventional Cardiology Unit, Hospital Álvaro Cunqueiro, Vigo, Spain.
Tomás Benito-GonzálezInterventional Cardiology Unit, Complejo Asistencial Universitario de Leon, Spain.
Carmen Garrote-ColomaInterventional Cardiology Unit, Complejo Asistencial Universitario de Leon, Spain.
Felipe Fernández-VázquezInterventional Cardiology Unit, Complejo Asistencial Universitario de Leon, Spain.
Pablo AvanzasInterventional Cardiology Unit, Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, Spain.
Miguel PiñónCardiac Surgery Department, Hospital Álvaro Cunqueiro, Vigo, Spain.
Isaac PascualInterventional Cardiology Unit, Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral regurgitation (MR) is the second most common valvular heart disease and its prevalence is increasing with population ageing. In the recent years we have witnessed the development of several transcatheter devices to correct MR in patients at high-risk for surgery. The majority of evidence regarding safety and efficacy of this new therapy comes from MitraClip studies. However, new alternatives on the field of valve repair have emerged with promising results. The aim of this review is to portrait the landscape of transcatheter mitral repair alternatives, from currently used devices to those that will have a role in the near future.

Indexed as

heart failuremitral regurgitation (MR)Percutaneous mitral valve repairtranscatheter

Identifiers

PMID32953763
PMCPMC7475444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.